Athersys (ATHX) Stock Research, Analysis & News
Quick Analysis on Athersys (ATHX) Stock as of May 24, 2013
 | Previous Closing Price $1.81 is above 50 day moving average of $1.71 |
| Previous Closing Price $1.81 is above 200 day moving average of $1.35 |
 | The Stock pays no dividend |
| The closing price $1.81 is more than 213.26% away from its one year target price of $5.67 |
 | Earning per Share $-0.506 is negative. Athersys is lossing money. |
| EBITDA $-18.4M is negative |
(See more information about Athersys (ATHX) Stock below)
Athersys (ATHX) Stock Profile Summary
Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products in various disease areas in the United States. Its product pipeline includes MultiStem, a novel allogeneic approach to stem cell therapy and regenerative medicine for treating a range of diseases. The company also develops orally active pharmaceutical products for the treatment of obesity and certain central nervous system disorders, including narcolepsy, excessive daytime sleepiness, and chronic fatigue, as well as other potential indications consisting of attention deficit hyperactivity disorder and other cognitive disorders, including schizophrenia. It has product co-development collaboration with Angiotech Pharmaceuticals, Inc. for the potential application of MultiStem in multiple cardiovascular indications, including myocardial infarction, peripheral vascular disease, and certain other indications. In addition, the company has a collaboration agreement with Pfizer Inc. to develop and commercialize MutiStem for the treatment of inflammatory bowel disease. Athersys, Inc. was founded in 1995 and is based in Cleveland, Ohio.
Athersys (ATHX) Stock Key Statistics Research and Analysis as of May 24, 2013
| Stock Exchange | NCM |
| Market Capitalization | $93.0M
|
| Trade Volume (Average Trading Volume) | 591,005 (976,371) |
| Price/Sales | 15.39 |
| Price/Book | 7.45 |
| Earning/Share | $-0.506 |
| Current Year EPS Estimate | $-0.52 |
| Next Year EPS Estimate | $-0.42 |
| Previous Closing Price | $1.81 |
| 50 Day Price Moving Average | $1.71 |
| 200 Day Price Moving Average | $1.35 |
| 1 yr Target Price | $5.67 |
| Short Ratio | 0.60 |
| EBITDA | $-18.4M |
Latest Market News on Athersys (ATHX)
Click here to find the latest news on Athersys (ATHX)
Looking for Market Opportunties?
Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center
Research on Athersys (ATHX)
